- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06778590
Comparison of Piezoelectric and Conventional Surgery for Germectomy of the Lower Third Molar (Germectomy)
January 15, 2025 updated by: Amerigo Giudice
Comparison of Piezoelectric and Conventional Surgery for Germectomy of the Lower Third Molar: Assessment of Post-operative Sequelae
The main objective of the study is to compare the effects of the piezoelectric surgery and the traditional technique on soft tissue edema in patients undergoing bilateral germectomy of mandibular third molars
Study Overview
Status
Recruiting
Conditions
Detailed Description
The main objective of the study is to compare the effects of piezoelectric surgery and the traditional technique on soft tissue edema in patients undergoing bilateral germectomy of mandibular third molars.
Post-operative swelling is analyzed using a photogrammetry facial scanner (Marathon MT-4000).
Study Type
Interventional
Enrollment (Estimated)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Amerigo Giudice, Prof, MD, PhD
- Phone Number: 09613647215
- Email: a.giudice@unicz.it
Study Locations
-
-
-
Catanzaro, Italy, 88100
- Recruiting
- Magna Graecia University of Catanzaro
-
Contact:
- Amerigo Giudice, Prof-MD-PhD
- Phone Number: 09613647215
- Email: a.giudice@unicz.it
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Patients aged between 14 and 24 years, with both lower third molars in the developmental stage (with incompletely formed roots) and requiring extraction of both for prophylactic, therapeutic or strategic reasons
- Good quality of radiographic investigations (CBCT)
- Good health status
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Test group: Piezoelectric Surgery
Use of piezoelectric technique in third molar germectomy procedures
|
Application of piezoelectric technique in third molar germectomy procedures
|
|
Active Comparator: Control group: Traditional Surgery
Use of traditional technique in third molar germectomy procedures
|
Application of traditional technique in third molar germectomy procedures
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Facial swelling qualitative analysis
Time Frame: Change from baseline (before surgery) at 2 day after surgery and at 7 days after surgery
|
To compare the effectiveness of piezosurgery in reducing facial swelling using qualitative three-dimensional analysis (measured by colorimetric variation given by the overlapping volumes)
|
Change from baseline (before surgery) at 2 day after surgery and at 7 days after surgery
|
|
Facial swelling quantitative analysis - volumetric differences
Time Frame: Change from baseline (before surgery) at 2 day after surgery and at 7 days after surgery
|
To compare the effectiveness of piezosurgery in reducing facial swelling using quantitative three-dimensional analysis ( volumes measured in cm3)
|
Change from baseline (before surgery) at 2 day after surgery and at 7 days after surgery
|
|
Facial swelling quantitative analysis - linear differences
Time Frame: Change from baseline (before surgery) at 2 day after surgery and at 7 days after surgery
|
To compare the effectiveness of piezosurgery in reducing facial swelling using quantitative three-dimensional analysis (linear differences measured in cm2)
|
Change from baseline (before surgery) at 2 day after surgery and at 7 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trismus analysis
Time Frame: Change from baseline (before surgery) at 2 day after surgery and at 7 days after surgery
|
To assess the effects of piezosurgery on trismus (measured in cm)
|
Change from baseline (before surgery) at 2 day after surgery and at 7 days after surgery
|
|
Pain analysis with Visual analogue scale (VAS)
Time Frame: Change from baseline (before surgery) at 2 day after surgery and at 7 days after surgery
|
To assess the effects of piezosurgery on pain (measured by VAS-score from 0 to 10 point, with 10 as the worst outcome.
|
Change from baseline (before surgery) at 2 day after surgery and at 7 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2024
Primary Completion (Estimated)
August 31, 2025
Study Completion (Estimated)
October 31, 2025
Study Registration Dates
First Submitted
January 12, 2025
First Submitted That Met QC Criteria
January 15, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 15, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 372/2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.